Individuals With Higher CD4/CD8 Ratio Exhibit Increased Risk of Acute Respiratory Distress Syndrome and In-Hospital Mortality During Acute SARS-CoV-2 Infection

CD4/CD8 ratio has been used as a quantitative prognostic risk factor in patients with viral infections. This study aims to assess the association between in-hospital mortality and at admission CD4/CD8 ratio among individuals with acute SARS-CoV-2 infection. This is a longitudinal cohort study with d...

Descripción completa

Detalles Bibliográficos
Autores: Pascual-Dapena, Ana, Chillaron, Juan Jose|||0000-0002-8096-1703, Llauradó, Gemma|||0000-0002-3237-6366, Arnau-Barrés, Isabel, Flores, Juana, Lopez-Montesinos, Inmaculada, Sorlí, Luisa|||0000-0001-9562-514X, Luis Martínez-Pérez, Juan, Gómez-Zorrilla, Silvia|||0000-0002-5987-068X, Du, Juan, Garcia-Giralt, Natalia|||0000-0001-6507-0147, Güerri-Fernández, Robert|||0000-0002-9794-9161
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:282233
Acceso en línea:https://ddd.uab.cat/record/282233
https://dx.doi.org/urn:doi:10.3389/fmed.2022.924267
Access Level:acceso abierto
Palabra clave:ARDS
CD4/CD8 ratio
Mortality
Prognose
SARS-CoV-2
Descripción
Sumario:CD4/CD8 ratio has been used as a quantitative prognostic risk factor in patients with viral infections. This study aims to assess the association between in-hospital mortality and at admission CD4/CD8 ratio among individuals with acute SARS-CoV-2 infection. This is a longitudinal cohort study with data of all consecutive patients admitted to the COVID-19 unit at Hospital del Mar, Barcelona, Spain for ≥48 h between March to May 2020. The CD4+ CD8+ T-cell subset differentiation was assessed by flow cytometry at admission as well as a complete blood test. Patients were classified according to CD4/CD8 ratio tertiles. The primary outcome was in-hospital mortality and the secondary outcome was acute respiratory distress (ARDS). A total of 338 patients were included in the cohort. A high CD4/CD8 ratio (third tertile) was associated with a higher in-hospital mortality [adjusted Cox model hazard ratio (HR) 4.68 (95%CI 1.56-14.04, p = 0.006), reference: second tertile HR 1]. Similarly, a high CD4/CD8 ratio (third tertile) was associated with a higher incidence of ARDS [adjusted logistic regression model OR 1.97 (95%CI 1.11-3.55, p = 0.022) reference: second tertile HR 1]. There was a trend of higher in-hospital mortality and incidence of ARDS in patients within the first tertile of CD4/CD8 ratio compared with the second one, but the difference was not significant. No associations were found with total lymphocyte count or inflammatory parameters, including D-dimer. CD4/CD8 ratio is a prognostic factor for the severity of COVID-19, reflecting the negative impact on prognosis of those individuals whose immune response has abnormal CD8+ T-cell expansion during the early response to the infection.